Lau Associates’s Novartis NVS Stock Holding History

Lau Associates’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$866K	Buy	9,559 +6,251	+189%	+$561K	0.43%	52
2019 Q3	$287K	Hold	3,308	–	–	0.15%	82
2019 Q2	$302K	Sell	3,308 -384	-10%	-$32.5K	0.14%	77
2019 Q1	$318K	Hold	3,692	–	–	0.16%	74
2018 Q4	$284K	Hold	3,692	–	–	0.16%	83
2018 Q3	$285K	Sell	3,692 -744	-17%	-$55K	0.16%	79
2018 Q2	$300K	Hold	4,436	–	–	0.21%	64
2018 Q1	$321K	Hold	4,436	–	–	0.25%	63
2017 Q4	$334K	Hold	4,436	–	–	0.26%	61
2017 Q3	$341K	Hold	4,436	–	–	0.26%	61
2017 Q2	$332K	Hold	4,436	–	–	0.27%	62
2017 Q1	$295K	Hold	4,436	–	–	0.26%	67
2016 Q4	$290K	Hold	4,436	–	–	0.29%	62
2016 Q3	$314K	Hold	4,436	–	–	0.32%	63
2016 Q2	$328K	Hold	4,436	–	–	0.35%	62
2016 Q1	$288K	Hold	4,436	–	–	0.3%	62
2015 Q4	$342K	Hold	4,436	–	–	0.37%	54
2015 Q3	$365K	Hold	4,436	–	–	0.43%	50
2015 Q2	$391K	Hold	4,436	–	–	0.38%	52
2015 Q1	$392K	Sell	4,436 -558	-11%	-$49.5K	0.37%	51
2014 Q4	$415K	Hold	4,994	–	–	0.38%	52
2014 Q3	$421K	Hold	4,994	–	–	0.39%	48
2014 Q2	$405K	Hold	4,994	–	–	0.36%	50
2014 Q1	$380K	Hold	4,994	–	–	0.34%	52
2013 Q4	$360K	Hold	4,994	–	–	0.32%	52
2013 Q3	$343K	Hold	4,994	–	–	0.29%	48
2013 Q2	$316K	Buy	+4,994	New	+$325K	0.27%	54

Other funds holding NVS

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return

Lau Associates's NVS Position: Q4 2019 in Review

Lau Associates increased its Novartis (NVS) stake by 189% in Q4 2019, buying an estimated $561K and bringing the position to 9,559 shares worth $866K. The position accounts for 0.43% of the portfolio, ranked #52.

Lau Associates first reported a position in NVS in Q2 2013 and has held it in 27 quarters since. 1,172 funds tracked by Wall St. Rank hold NVS as of Q4 2019.

Lau Associates held 9,559 shares of Novartis worth $866K as of Q4 2019.
Lau Associates bought 6,251 Novartis shares in Q4 2019, an estimated $561K.
Novartis made up 0.43% of Lau Associates's portfolio in Q4 2019, its #52 holding.
Lau Associates first reported a position in Novartis in Q2 2013 and has held it in 27 quarters since.
1,172 funds tracked by Wall St. Rank held Novartis as of Q4 2019.

Based on Lau Associates's 13F filing for Q4 2019, filed 5 Feb 2020.